Literature DB >> 8726397

A comparison of the skeletal effects of intermittent and continuous administration of calcitonin in ovariectomized rats.

M Li1, Y Shen, K W Burton, P P DeLuca, R C Mehta, B D Baumann, T J Wronski.   

Abstract

The study was designed to compare the skeletal effects of intermittent and continuous administration of calcitonin (CT) in ovariectomized (OVX) rats. Female rats were sham operated or OVX at 3 months of age and treated for 6 weeks with vehicle or salmon CT. Sham-operated control rats were injected subcutaneously with vehicle on alternate days. One group of OVX rats was treated with vehicle intermittently by subcutaneous injection or continuously via Alzet osmotic minipumps. The remaining OVX rats were treated with CT by either subcutaneous injections (16 U/kg) on alternate days or by continuous infusion via minipumps at a daily dose of 8 U/kg. OVX rats treated with CT continuously were mildly hypocalcemic compared with all other groups. The proximal tibial metaphyses of vehicle-treated OVX rats were osteopenic with a cancellous bone volume at only 28% of the vehicle-treated control level. This bone loss was associated with increased indices of bone turnover such as osteoclast surface, osteoblast surface, and bone formation rate. Cancellous bone volume in OVX rats treated with CT either intermittently or continuously was significantly higher than that of vehicle-treated OVX rats, but lower than that of vehicle-treated control rats. Treatment of OVX rats with intermittent or continuous CT significantly decreased all indices of bone turnover compared with vehicle-treated OVX rats. However, osteoclast and osteoblast surfaces of OVX rats treated with CT continuously were still significantly higher than those of vehicle-treated control rats. These results indicate that intermittent and continuous administration of CT had similar skeletal effects in OVX rats. Both treatment regimens depressed bone turnover and partially prevented cancellous bone loss in the estrogen-deplete skeleton.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8726397     DOI: 10.1016/8756-3282(96)00014-2

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  6 in total

1.  The effects of salmon calcitonin-induced hypocalcemia on bone metabolism in ovariectomized rats.

Authors:  Rachel A Davey; Howard A Morris
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

2.  Skeletal effects of parathyroid hormone (1-34) in ovariectomized rats with or without concurrent administration of salmon calcitonin.

Authors:  P P DeLuca; B A Dani
Journal:  AAPS PharmSci       Date:  2001

3.  The inhibitory effect of salmon calcitonin on intervertebral disc degeneration in an ovariectomized rat model.

Authors:  Yang Luo; Liu Zhang; Wen-Ya Wang; Qi-Feng Hu; Hui-Ping Song; Ying-Ze Zhang
Journal:  Eur Spine J       Date:  2014-10-11       Impact factor: 3.134

4.  Effectiveness of combined salmon calcitonin and aspirin therapy for osteoporosis in ovariectomized rats.

Authors:  Jinsong Wei; Jian Wang; Yan Gong; Rong Zeng
Journal:  Mol Med Rep       Date:  2015-04-16       Impact factor: 2.952

5.  The biochemical and histological analysis of subcutaneous calcitonin and intramedullary methylprednisolone on bone repair after bone marrow ablation: an experimental comparative study in rats.

Authors:  Salim Ersozlu; Bartu Sarisozen; Ozgur Ozer; Saduman Balaban Adim; Orcun Sahin
Journal:  J Exp Orthop       Date:  2017-07-20

6.  Protective effect of calcitonin on lumbar fusion-induced adjacent-segment disc degeneration in ovariectomized rat.

Authors:  Chang-Cheng Liu; Fa-Ming Tian; Zhuang Zhou; Peng Wang; Yu Gou; Heng Zhang; Wen-Ya Wang; Yong Shen; Ying-Ze Zhang; Liu Zhang
Journal:  BMC Musculoskelet Disord       Date:  2015-11-09       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.